Evaluating the clinical benefit of brain-computer interfaces for control of a personal computer.

BCI activities of daily living brain-machine interface clinical trial communication health-related quality of life patient-reported outcomes

Journal

Journal of neural engineering
ISSN: 1741-2552
Titre abrégé: J Neural Eng
Pays: England
ID NLM: 101217933

Informations de publication

Date de publication:
11 04 2022
Historique:
received: 07 10 2021
accepted: 24 03 2022
pubmed: 25 3 2022
medline: 14 4 2022
entrez: 24 3 2022
Statut: epublish

Résumé

Brain-computer interfaces (BCIs) enabling the control of a personal computer could provide myriad benefits to individuals with disabilities including paralysis. However, to realize this potential, these BCIs must gain regulatory approval and be made clinically available beyond research participation. Therefore, a transition from engineering-oriented to clinically oriented outcome measures will be required in the evaluation of BCIs. This review examined how to assess the clinical benefit of BCIs for the control of a personal computer. We report that: (a) a variety of different patient-reported outcome measures can be used to evaluate improvements in

Identifiants

pubmed: 35325875
doi: 10.1088/1741-2552/ac60ca
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

Creative Commons Attribution license.

Auteurs

Adam Fry (A)

Department of Rehabilitation and Human Performance, Icahn School of Medicine at Mount Sinai, New York, United States of America.

Ho Wing Chan (HW)

Department of Neurology, Icahn School of Medicine at Mount Sinai, New York, United States of America.

Noam Y Harel (NY)

Department of Rehabilitation and Human Performance, Icahn School of Medicine at Mount Sinai, New York, United States of America.
Department of Neurology, Icahn School of Medicine at Mount Sinai, New York, United States of America.
James J. Peters Veterans Affairs Medical Center, New York, United States of America.

Lisa A Spielman (LA)

Department of Rehabilitation and Human Performance, Icahn School of Medicine at Mount Sinai, New York, United States of America.

Miguel X Escalon (MX)

Department of Rehabilitation and Human Performance, Icahn School of Medicine at Mount Sinai, New York, United States of America.

David F Putrino (DF)

Department of Rehabilitation and Human Performance, Icahn School of Medicine at Mount Sinai, New York, United States of America.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH